Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales
TheStreet.com
Fri, 02/7/20 - 10:54 am
Tags:
AbbVie, earnings
AbbVie Reports Successful Trial Results for Arthritis Drug
Motley Fool
Wed, 02/5/20 - 10:00 pm
Tags:
AbbVie, Rinvoq, Upadacitinib, psoriasis, clinical trials
Allergan unveils new Botox plant ahead of $63B AbbVie merger
Fierce Pharma
Tue, 01/28/20 - 12:02 pm
Tags:
AbbVie, Allergan, Botox, Ireland, drug manufacturing
AbbVie's HIV Drug Aluvia Seen as Potential Treatment for Coronavirus
BioSpace
Mon, 01/27/20 - 10:51 pm
Tags:
AbbVie, Aluvia, Wuhan Coronavirus, China
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Mon, 01/27/20 - 10:57 am
Tags:
Allergan, AbbVie, AstraZeneca, M&A, Nestle
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis
Motley Fool
Wed, 01/15/20 - 10:56 am
Tags:
AbbVie, Boehringer Ingelheim, Skyrizi, Novartis, Cosentyx, psoriasis
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
Fri, 01/10/20 - 11:55 pm
Tags:
AbbVie, Allergan, antitrust, M&A, brazikumab, Europe
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
Tags:
M&A, AbbVie, Allergan, Astellas, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
AbbVie answers Allergan aesthetics worries with separate new unit
Fierce Pharma
Wed, 01/8/20 - 12:16 pm
Tags:
AbbVie, Allergan, aesthetics, M&A, Allergan Aesthetics
Should AbbVie break up Allergan? If it wants to make up for Humira, then yes, analyst says
Fierce Pharma
Tue, 01/7/20 - 10:49 pm
Tags:
AbbVie, Allergan, M&A, Humira, Botox
In last-minute deal, Allergan forks over a hefty $300M to settle pay-for-delay dispute
Fierce Pharma
Mon, 01/6/20 - 11:32 pm
Tags:
AbbVie, Allergan, M&A, pay-for-delay, Warner Chilcott, Watson Pharmaceuticals
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
Tags:
M&A, Bristol-Myers Squibb, Celgene, AbbVie, Allergan, Roche, Spark Therapeutics, Novartis, The Medicines Company, Alkermes, Rodin Therapeutics, Sumitomo Dainippon, Roivant
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
Fierce Pharma
Thu, 01/2/20 - 10:46 am
Tags:
drug pricing, Pfizer, Bristol-Myers Squibb, AbbVie
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
Tags:
drug ads, television ads, Roche, Ocrevus, GSK, Dovato, AbbVie, Humira
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
Tags:
M&A, Sanofi, Merck, AbbVie, Allergan, Bristol-Myers Squibb, Celgene, FTC
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Tue, 12/10/19 - 11:53 pm
Tags:
Merck, Eli Lilly, AbbVie, JNJ, Imbruvica, ARQ 531, LOXO-305, CLL, ASH2019
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
BioSpace
Mon, 12/9/19 - 11:18 pm
Tags:
AbbVie, Scripps Research Institute, cancer, immunology, fibrosis
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
Tags:
AstraZeneca, cancer, Calquence, ASH2019, Imbruvica, JNJ, AbbVie, CLL
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
Sun, 12/8/19 - 10:12 pm
Tags:
AbbVie, Roche, CLL, ASH2019, Venclexta
UCB posts more supportive data from Humira rival bimekizumab
Pharmaforum
Fri, 12/6/19 - 09:31 pm
Tags:
UCB Pharma, bimekizumab, AbbVie, Humira, psoriasis, biosimilars

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.